tirzepatide eu approval Eli Lilly submits for in US and EU committee backs extending use

Advertisement Article continues below this ad

If long-term use aligns with your goals and your prescriber supports it, maintenance dosing (2.55mg weekly) is increasingly common

Training, protein intake, sleep, and calorie control still drive most of your before and after results with MOTS-c

Tirzepatide may increase fertility in women with metabolic dysfunction

The SURMOUNT-4 trial, which studied patients who stopped tirzepatide after achieving weight loss, found that lipid parameters regressed toward baseline within 17 weeks of discontinuation

GLP-1 plays a vital role in regulating appetite and controlling blood sugar levels